Product Description
The global on-pump coronary artery bypass device market was valued at $583.3 million in 2025. This is expected to increase over the forecast period at a CAGR of 3% to reach $719.6 million by 2032.
The full report suite on the global market for on-pump coronary artery bypass (ONCAB) device includes disposable kits and perfusion system devices.
The report includes data for 65+ countries across 7 different regions which include North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific and Africa.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global On-Pump Coronary Artery Bypass Device Market Trends
The global volume of coronary artery bypass grafting procedures has declined in recent years as less invasive interventional alternatives continue to gain traction. In particular, the rapid adoption of transcatheter aortic valve replacement (TAVR) has shifted treatment patterns toward catheter-based therapies that offer shorter hospital stays and faster recovery compared with traditional open-heart surgery. As TAVR indications expand and procedural volumes continue to rise worldwide, this shift is expected to constrain overall growth in the on-pump coronary artery bypass device market over the forecast period, despite the continued role of surgical revascularization in complex or high-risk patients.
Global On-Pump Coronary Artery Bypass Device Market Share Insights
- LivaNova was the leading competitor in the global on-pump coronary artery bypass market in 2025, holding a strong leadership position across both the perfusion system and disposable segments. The company has continued to invest in innovation within the ONCAB space, including the launch and geographic expansion of its next-generation Essenz™ Perfusion System, which was introduced into the Chinese market in 2025 and features enhanced real-time monitoring and system integration capabilities. Supported by its broad product portfolio, installed base, and ongoing platform upgrades, LivaNova is well positioned to maintain and potentially expand its market share over the coming years.
- Terumo was the second-leading competitor in the on-pump coronary artery bypass device market in 2025. Terumo offers its Prestige Pack™ cardiovascular procedure kit as its disposable kit option along with the CAPIOX® and Sarns™ lines of multiple disposable perfusion products. Due to the presence of regional companies rising in popularity, Terumo is expected to maintain its current market share over the coming years.
- Medtronic was the third-leading competitor in the on-pump coronary artery bypass device market in 2025. Medtronic offers tubing sets, cardioplegia and arterial filters as its disposable kits. The company has been at the leading edge of developing more biocompatible surfaces with heparin-coated oxygenators, as seen with the Cortiva® and Trillium® bioactive surfaces. Since Medtronic has left the ventricular assist device market, it is expected that it will expand its presence in the THVR segment.
Global On-Pump Coronary Artery Bypass Device Market Segmentation Summary
- On-Pump Coronary Artery Bypass Disposable Market
- On-Pump Coronary Artery Bypass Perfusion System Market
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis for Top Competitors, Mergers & Acquisitions, Emerging Markets & Technologies, Key Analysis Updates. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
